Description

CJC-1295 + DAC — Long-Acting GHRH Analog

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of growth-hormone-releasing hormone (GHRH). The DAC modification binds to serum albumin, dramatically extending the peptide’s half-life and making it one of the most studied long-acting GHRH analogs in laboratory research.

Research Applications

CJC-1295 + DAC has been investigated for its ability to stimulate sustained pulses of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) through the GHRH receptor. Its extended duration of action makes it a valuable reference compound in studies of the GH/IGF-1 axis, body composition, and recovery pathways.

Specifications

• Purity: ≥99% (HPLC verified)
• Quantity: 5mg per vial
• Form: Lyophilized powder
• Storage: Store at -20°C; reconstituted solution stable at 2–8°C for up to 14 days
• CAS: 863288-34-0

For laboratory and research use only. Not for human or animal consumption.